BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma

CSL Behring Underscores its Commitment to Respiratory Patients with Strong Focus on Research

Focusing on what we have learnt about the impact of global Covid-19 pandemic on pulmonary disease research, it will also explore the latest updates in the ...

September 06, 2021 | News

H1 BioPharma 2021 Deals review report 2021

The biopharma sector has always been seen as a safe harbor in times of economic uncertainty — the need for medical innovations to improve human healt...

September 03, 2021 | News

Pfizer Starts PhIII Clinical Trial in Adults for Its Vaccine Against Respiratory Syncytial Virus (RSV)

Pfizer Inc. (NYSE:PFE) today announced the initiation of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV disease), a...

September 02, 2021 | News

CPC Launches New MicroCNX Connectors, a First for Small-Volume Biopharma Processing

CPC (Colder Products Company), part of Dover (NYSE: DOV) and maker of a broad range of single-use connectors, today announced the laun...

September 02, 2021 | News

Avantor® Announces Investment in Hydration Capabilities to Address Growing Demand for Biologics

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologi...

September 01, 2021 | News

Poseida announces FDA clearance of IND for its first fully CAR-T therapy for patients with multiple myeloma.

Poseida Therapeutics, Inc. , a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell ...

August 30, 2021 | News

Insilico Medicine & 4B Technologies to advance the development of innovative small molecule therapies

Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)-driven drug discovery company, and 4B Technologies Co., Ltd. ("4B ...

August 30, 2021 | News

Pharmac to fund new cardiovascular medicine with amended Special Authority criteria

People with at high-risk of cardiovascular disease, who meet the funding criteria, will be able to access funded rosuvastatin from 1 December 2021. &ldquo...

August 29, 2021 | News

ExoCoBio to Build the World’s First Clinical Grade Exosome GMP Manufacturing Facility

ExoCoBio will invest approximately US $20M to build the EGMP facility whose project actually started in 2019, and after two years of intensive ...

August 26, 2021 | News

McMaster, Sartorius Stedim Biotech team up to advance biomanufacturing processes with next-gen tech

Using a state-of-the-art multi-column chromatography system provided by Sartorius Stedim Biotech, the McMaster team will “perfect” a proc...

August 23, 2021 | News

Discovery Technologies: The Story of Remdesivir

Molecular Structure and Mode of Action Remdesivir, also known as GS-5734, is a carbolic ester with the molecular formula C27H35N6O8P. In vivo, remdes...

August 23, 2021 | Opinion

Insilico,BioNova to Develop Small Molecule Drugs

Insilico Medicine ("Insilico"), an end-to-end artificial intelligence-driven drug discovery company, and BioNova Pharmaceuticals (Shanghai) Ltd. ("BioNova"...

August 23, 2021 | News

Daewoong Pharma, Hanall Biopharma Invest $1M USD in Alloplex Biotherapeutics

Daewoong Pharmaceutical and Hanall Biopharma of South Korea are expanding their global open collaboration initiative by investing in Alloplex Bio...

August 20, 2021 | News

Senhwa's Silmitasertib Receives US FDA Fast Track Designation

Senhwa Biosciences, Inc., a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, today ann...

August 19, 2021 | News

Stay Connected